L-Arginine/nitric oxide regulates skeletal muscle development via muscle fibre-specific nitric oxide/mTOR pathway in chickens

被引:2
|
作者
Ruxia Wang [1 ,2 ]
Kelin Li [1 ]
Li Sun [1 ]
Hongchao Jiao [1 ]
Yunlei Zhou [1 ]
Haifang Li [1 ]
Xiaojuan Wang [1 ]
Jingpeng Zhao [1 ]
Hai Lin [1 ]
机构
[1] Key Lab for Animal Biotechnology and Disease Control, Department of Animal Science, Shandong Agricultural University
[2] Institute of Biological Resources, Jiangxi Academy of Sciences
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
S831.5 [饲料与营养];
学科分类号
090502 ;
摘要
L-Arginine(L-Arg), the precursor of nitric oxide(NO), plays an important role in muscle function. Fast-twitch glycolytic fibres are more susceptible to age-related atrophy than slow-twitch oxidative fibres.The effect of L-Arg/NO on protein metabolism of fast-and slow-twitch muscle fibres was evaluated in chickens. In Exp. 1, 48 chicks at 1 day old were divided into 4 groups of 12 birds and subjected to 4 treatments: basal diet without supplementation or supplemented with 1% L-Arg, and water supplemented with or without L-nitro-arginine methyl ester(L-NAME, 18.5 mM). In Exp. 2, 48 chicks were divided into 4 groups of 12 birds fed with the basal diet and subjected to the following treatments: tap water(control), tap water supplemented with L-NAME(18.5 m M), or molsidomine(MS, 0.1 mM), or 18.5 mM L-NAME + 0.1 mM MS(NAMS). The regulatory effect of L-Arg/NO was further investigated in vitro with myoblasts obtained from chicken embryo pectoralis major(PM) and biceps femoris(BF).In vivo, dietary L-Arg supplementation increased breast(+14.94%, P < 0.05) and thigh muscle mass(+23.40%, P < 0.05); whereas, MS treatment had no detectable influence. However, L-NAME treatment blocked the beneficial influence of L-Arg on muscle development. L-Arg decreased(P < 0.05) protein synthesis rate, phosphorylated mTOR and ribosomal protein S6 kinase beta-1(p70S6K) levels in breast muscle, which was recovered by L-NAME treatment. In vitro, L-Arg or sodium nitroprusside(SNP)reduced protein synthesis rate, suppressed phosphorylated m TOR/p70S6K and decreased atrogin-1 and muscle RING finger 1(MuRF1) in myoblasts from PM muscle(P < 0.05). L-NAME abolished the inhibitory effect of L-Arg on protein synthesis and the m TOR/p70S6K pathway. However, myoblasts from BF muscle showed the weak influence. Moreover, blocking the mTOR/p70S6K pathway with rapamycin suppressed protein synthesis of the 2 types of myoblasts; whereas, the protein expression of atrogin-1 and MuRF1 levels were restricted only in myoblasts from PM muscle. In conclusion, L-Arg/NO/mTOR/p70S6K pathway enhances protein accumulation and muscle development in fast-twitch glycolytic muscle in chickens. L-Arg/NO regulates protein turnover in a muscle fibre specific way, which highlights the potential clinical application in fast-twitch glycolytic muscle fibres.
引用
收藏
页码:68 / 85
页数:18
相关论文
共 50 条
  • [21] Physiology of nitric oxide in skeletal muscle
    Stamler, JS
    Meissner, G
    PHYSIOLOGICAL REVIEWS, 2001, 81 (01) : 209 - 237
  • [22] Role of the L-arginine nitric oxide pathway in hypoxic fetoplacental vasoconstriction
    Byrne, BM
    Howard, RB
    Morrow, RJ
    Whiteley, KJ
    Adamson, SL
    PLACENTA, 1997, 18 (08) : 627 - 634
  • [23] Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases
    Cooke, JP
    Dzau, VJ
    CIRCULATION, 1997, 96 (02) : 379 - 382
  • [24] THE ENDOTHELIAL L-ARGININE NITRIC-OXIDE PATHWAY AND THE RENAL CIRCULATION
    LUSCHER, TF
    BOCK, HA
    KLINISCHE WOCHENSCHRIFT, 1991, 69 (13): : 603 - 609
  • [25] Interactions between L-arginine supplementation and physical training in the mitochondrial biomarkers and nitric oxide bioavailability in rat skeletal muscle
    Zanesco, Angelina
    da Silva, Carmem V.
    Delbin, Maria A.
    La Guardia, Paolo G.
    Davel, Ana P.
    Priviero, Fernanda B.
    FASEB JOURNAL, 2013, 27
  • [26] MANIPULATION OF THE L-ARGININE NITRIC-OXIDE PATHWAY IN EXPERIMENTAL COLITIS
    NEILLY, PJD
    KIRK, SJ
    GARDINER, KR
    ANDERSON, NH
    ROWLANDS, BJ
    BRITISH JOURNAL OF SURGERY, 1995, 82 (09) : 1188 - 1191
  • [27] L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle
    Huk, I
    Nanobashvili, J
    Neumayer, C
    Punz, A
    Mueller, M
    Afkhampour, K
    Mittlboeck, M
    Losert, U
    Polterauer, P
    Roth, E
    Patton, S
    Malinski, T
    CIRCULATION, 1997, 96 (02) : 667 - 675
  • [28] ROLE OF THE L-ARGININE-NITRIC OXIDE PATHWAY IN VASCULAR SMOOTH-MUSCLE
    SCHINI, VB
    VANHOUTTE, PM
    EUROPEAN HEART JOURNAL, 1993, 14 : 16 - 21
  • [29] Expression of nitric oxide synthase in bladder smooth muscle cells: Regulation by cytokines and L-arginine
    Johansson, RK
    Poljakovic, M
    Andersson, KE
    Persson, K
    JOURNAL OF UROLOGY, 2002, 168 (05): : 2280 - 2285
  • [30] Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium
    Durante, W
    Liao, L
    Iftikhar, I
    OBrien, WE
    Schafer, AI
    CIRCULATION RESEARCH, 1996, 78 (06) : 1075 - 1082